Top

European Journal of Nutrition

Published in:

01-08-2015 | Original Contribution

Sesamol and sesame (Sesamum indicum) oil enhance macrophage cholesterol efflux via up-regulation of PPARγ1 and LXRα transcriptional activity in a MAPK-dependent manner

Authors: Amin F. Majdalawieh, Hyo-Sung Ro

Published in: European Journal of Nutrition | Issue 5/2015

Abstract

Purpose

Cholesterol clearance by macrophages is a vital process to eliminate excess cholesterol from the body. Internalization of modified cholesterol by macrophages triggers overexpression of peroxisome proliferator-activated receptor γ1 (PPARγ1) and liver X receptor α (LXRα), two transcription factors that are critically involved in macrophage cholesterol efflux. Recent studies demonstrate that oral administration of sesamol derivative (INV-403) and sesame oil leads to a significant attenuation of atherosclerosis in Watanabe heritable hyperlipidemic rabbits and LDLR^−/− mice, respectively. However, the exact molecular mechanisms underlying such anti-atherogenic effects remain largely unrevealed.

Methods

Luciferase reporter assays were performed to assess the effects of sesamol and sesame oil on PPARγ1 and LXRα gene expression. The potential of sesamol and sesame oil to modulate cholesterol efflux was evaluated using ³H-cholesterol efflux assays.

Results

Sesamol and sesame oil treatments lead to a significant up-regulation of PPARγ1 and LXRα expression and transcriptional activity in a MAPK-dependent manner. Importantly, primary macrophages display a significantly enhanced cholesterol efflux potential upon treatment with sesamol and sesame oil, and this stimulatory effect is mediated by MAPK signaling.

Conclusions

Our findings suggest that the previously reported anti-atherogenic effects of sesamol and sesame oil could be attributed, at least in part, to enhanced PPARγ1 and LXRα expression and transcriptional activity leading to improved macrophage cholesterol efflux. Our study is novel in elucidating the molecular and cellular mechanisms underlying the protective effects of sesamol and sesame oil against atherosclerosis.

Lusis AJ (2000) Atherosclerosis. Nature 407:233–241CrossRef

Breslow JL (1997) Cardiovascular disease burden increases, NIH funding decreases. Nat Med 3:600–601CrossRef

Steinberg D (2002) Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 8:1211–1217CrossRef

Majdalawieh A, Ro HS (2010) PPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1. Nucl Recept Signal 8:e004

Ricote M, Huang J, Fajas L, Li A, Welch J, Najib J et al (1998) Expression of the peroxisome proliferator-activated receptor γ (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc Natl Acad Sci USA 95:7614–7619CrossRef

Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM (1998) PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93:241–252CrossRef

Langmann T, Klucken J, Reil M, Liebisch G, Luciani MF, Chimini G et al (1999) Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem Biophys Res Commun 257:29–33CrossRef

Venkateswaran A, Laffitte BA, Joseph SB, Mak PA, Wilpitz DC, Edwards PA et al (2000) Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα. Proc Natl Acad Sci USA 97:12097–12102CrossRef

Klucken J, Buchler C, Orso E, Kaminski WE, Porsch-Ozcurumez M, Liebisch G et al (2000) ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proc Natl Acad Sci USA 97:817–822CrossRef

10.

Kuhad A, Sachdeva AK, Chopra K (2009) Attenuation of renoinflammatory cascade in experimental model of diabetic nephropathy by sesamol. J Agric Food Chem 57(14):6123–6128CrossRef

11.

Hsu DZ, Wan CH, Hsu HF, Lin YM, Liu MY (2008) The prophylactic protective effect of sesamol against ferric–nitrilotriacetate-induced acute renal injury in mice. Food Chem Toxicol 46(8):2736–2741CrossRef

12.

Hsu DZ, Chu PY, Li YH, Liu MY (2008) Sesamol attenuates diclofenac-induced acute gastric mucosal injury via its cyclooxygenase-independent antioxidative effect in rats. Shock 30(4):456–462CrossRef

13.

Chu PY, Hsu DZ, Hsu PY, Liu MY (2010) Sesamol down-regulates the lipopolysaccharide-induced inflammatory response by inhibiting nuclear factor-kappa B activation. Innate Immun 16(5):333–339CrossRef

14.

Lu YC, Jayakumar T, Duann YF, Chou YC, Hsieh CY, Yu SY et al (2011) Chondroprotective role of sesamol by inhibiting MMPs expression via retaining NF-κB signaling in activated SW1353 cells. J Agric Food Chem 59(9):4969–4978CrossRef

15.

Sharma AK, Bharti S, Bhatia J, Nepal S, Malik S, Ray R et al (2012) Sesamol alleviates diet-induced cardiometabolic syndrome in rats via up-regulating PPARγ, PPARα and e-NOS. J Nutr Biochem 23(11):1482–1489CrossRef

16.

Satchithanandam S, Chanderbhan R, Kharroubi AT, Calvert RJ, Klurfeld D, Tepper SA et al (1996) Effect of sesame oil on serum and liver lipid profiles in the rat. Int J Vitam Nutr Res 66:386–392

17.

Visavadiya NP, Narasimhacharya AV (2008) Sesame as a hypocholesteraemic and antioxidant dietary component. Food Chem Toxicol 46:1889–1895CrossRef

18.

Biswas A, Dhar P, Ghosh S (2010) Antihyperlipidemic effect of sesame (Sesamum indicum L.) protein isolate in rats fed a normal and high cholesterol diet. J Food Sci 75:274–279CrossRef

19.

Bhaskaran S, Santanam N, Penumetcha M, Parthasarathy S (2006) Inhibition of Atherosclerosis in Low density lipoprotein receptor-negative mice by sesame oil. J Med Food 9:487–490CrossRef

20.

Hsu DZ, Li YH, Chien SP, Liu MY (2004) Effects of sesame oil on oxidative stress and hepatic injury after cecal ligation and puncture in rats. Shock 21(5):466–469CrossRef

21.

Hsu DZ, Chien SP, Li YH, Chuang YC, Chang YC, Liu MY (2008) Sesame oil attenuates hepatic lipid peroxidation by inhibiting nitric oxide and superoxide anion generation in septic rats. JPEN J Parenter Enteral Nutr 32(2):154–159CrossRef

22.

Periasamy S, Hsu DZ, Chandrasekaran VR, Liu MY (2013) Sesame oil accelerates healing of 2,4,6-trinitrobenzenesulfonic acid-induced acute colitis by attenuating inflammation and fibrosis. JPEN J Parenter Enteral Nutr 37(5):674–682CrossRef

23.

Periasamy S, Hsu DZ, Chang PC, Liu MY (2014) Sesame oil attenuates nutritional fibrosing steatohepatitis by modulating matrix metalloproteinases-2, 9 and PPAR-γ. J Nutr Biochem 25(3):337–344CrossRef

24.

Majdalawieh A, Ro HS (2010) Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophages. Mediators Inflamm 2010:823821CrossRef

25.

Ying Z, Kherada N, Kampfrath T, Mihai G, Simonetti O, Desikan R et al (2011) A modified sesamol derivative inhibits progression of atherosclerosis. Arterioscler Thromb Vasc Biol 31(3):536–542CrossRef

26.

Majdalawieh AF, Hmaidan R, Carr RI (2010) Nigella sativa modulates splenocyte proliferation, Th1/Th2 cytokine profile, macrophage function and NK anti-tumor activity. J Ethnopharmacol 131(2):268–275CrossRef

27.

Bogachev O, Majdalawieh A, Pan X, Zhang L, Ro HS (2011) Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE(−/−) and LDLR(−/−) mice. Mol Med 17(9–10):1056–1064

28.

Majdalawieh A, Ro HS (2009) LPS-induced suppression of macrophage cholesterol efflux is mediated by adipocyte enhancer-binding protein 1. Int J Biochem Cell Biol 41(7):1518–1525CrossRef

29.

Fajas L, Auboeuf D, Raspe E, Schoonjans K, Lefebvre AM, Saladin R et al (1997) The organization, promoter analysis, and expression of the human PPARγ gene. J Biol Chem 272:18779–18789CrossRef

30.

Steffensen KR, Schuster GU, Parini P, Holter E, Sadek CM, Cassel T et al (2002) Different regulation of the LXRα promoter activity by isoforms of CCAAT/enhancer-binding proteins. Biochem Biophys Res Commun 293:1333–1340CrossRef

31.

Kim JB, Wright HM, Wright M, Spiegelman BM (1998) ADD1/SREBP1 activates PPARγ through the production of endogenous ligand. Proc Natl Acad Sci USA 95:4333–4337CrossRef

32.

Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, Mangelsdorf DJ (1995) LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 9:1033–1045CrossRef

33.

Majdalawieh A, Zhang L, Ro HS (2007) Adipocyte enhancer-binding protein-1 promotes macrophage inflammatory responsiveness by up-regulating NF-kappaB via IkappaBalpha negative regulation. Mol Biol Cell 18(3):930–942CrossRef

34.

He GP, Muise A, Li AW, Ro HS (1995) A eukaryotic transcriptional repressor with carboxypeptidase activity. Nature 378:92–96CrossRef

35.

Majdalawieh A, Zhang L, Fuki IV, Rader DJ, Ro HS (2006) Adipocyte enhancer-binding protein 1 is a potential novel atherogenic factor involved in macrophage cholesterol homeostasis and inflammation. Proc Natl Acad Sci USA 103(7):2346–2351CrossRef

36.

Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254CrossRef

37.

Eder K, Guan H, Sung HY, Francis SE, Crossman DC, Kiss-Toth E (2008) LDL uptake by monocytes in response to inflammation is MAPK dependent but independent of tribbles protein expression. Immunol Lett 116(2):178–183CrossRef

38.

Yin R, Dong YG, Li HL (2006) PPARgamma phosphorylation mediated by JNK MAPK: a potential role in macrophage-derived foam cell formation. Acta Pharmacol Sin 27(9):1146–1152CrossRef

39.

Yano M, Matsumura T, Senokuchi T, Ishii N, Murata Y, Taketa K et al (2007) Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages. Circ Res 100(10):1442–1451CrossRef

40.

Taketa K, Matsumura T, Yano M, Ishii N, Senokuchi T, Motoshima H et al (2008) Oxidized low density lipoprotein activates peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARgamma through MAPK-dependent COX-2 expression in macrophages. J Biol Chem 283(15):9852–9862CrossRef

41.

Bujold K, Rhainds D, Jossart C, Febbraio M, Marleau S, Ong H (2009) CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophages. Cardiovasc Res 83(3):457–464CrossRef

42.

Mulay V, Wood P, Manetsch M, Darabi M, Cairns R, Hoque M et al (2013) Inhibition of mitogen-activated protein kinase Erk1/2 promotes protein degradation of ATP binding cassette transporters A1 and G1 in CHO and HuH7 cells. PLoS ONE 8(4):e62667CrossRef

43.

Chang CC, Lu WJ, Ong ET, Chiang CW, Lin SC, Huang SY et al (2011) A novel role of sesamol in inhibiting NF-κB-mediated signaling in platelet activation. J Biomed Sci 18:93CrossRef

44.

Vennila L, Pugalendi KV (2012) Efficacy of sesamol on plasma and tissue lipids in isoproterenol-induced cardiotoxicity in Wistar rats. Arch Pharm Res 35(8):1465–1470CrossRef

45.

Kumar N, Mudgal J, Parihar VK, Nayak PG, Kutty NG, Rao CM (2013) Sesamol treatment reduces plasma cholesterol and triacylglycerol levels in mouse models of acute and chronic hyperlipidemia. Lipids 48(6):633–638CrossRef

46.

Wu WH, Kang YP, Wang NH, Jou HJ, Wang TA (2006) Sesame ingestion affects sex hormones, antioxidant status, and blood lipids in postmenopausal woman. J Nutr 136:1270–1275

47.

Korou LM, Agrogiannis G, Pantopoulou A, Vlachos IS, Iliopoulos D, Karatzas T et al (2010) Comparative antilipidemic effect of N-acetylcysteine and sesame oil administration in diet-induced hypercholesterolemic mice. Lipids Health Dis 9:23CrossRef

48.

Jan KC, Ho CT, Hwang LS (2008) Bioavailability and tissue distribution of sesamol in rat. J Agric Food Chem 56(16):7032–7037CrossRef

49.

Jan KC, Ho CT, Hwang LS (2009) Elimination and metabolism of sesamol, a bioactive compound in sesame oil, in rats. Mol Nutr Food Res 53(Suppl 1):S36–S43CrossRef

Title: Sesamol and sesame (Sesamum indicum) oil enhance macrophage cholesterol efflux via up-regulation of PPARγ1 and LXRα transcriptional activity in a MAPK-dependent manner
Authors: Amin F. Majdalawieh
Hyo-Sung Ro
Publication date: 01-08-2015
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Nutrition / Issue 5/2015
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-014-0747-3

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Sesamol and sesame (Sesamum indicum) oil enhance macrophage cholesterol efflux via up-regulation of PPARγ1 and LXRα transcriptional activity in a MAPK-dependent manner

Abstract

Purpose

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2015

The effect of green tea extract supplementation on exercise-induced oxidative stress parameters in male sprinters

Maternal supplementation of α-linolenic acid in normal and protein-restricted diets modulate lipid metabolism, adipose tissue growth and leptin levels in the suckling offspring

Feasibility of dietary assessment methods, other tools and procedures for a pan-European food consumption survey among infants, toddlers and children

Angiotensin II alters the expression of duodenal iron transporters, hepatic hepcidin, and body iron distribution in mice

Response to Letter to the Editor from Dr. Guilford

Choline concentrations are lower in postnatal plasma of preterm infants than in cord plasma

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page